video corpo

Water purification unit for the pharmaceutical industry PHARMADION
reverse osmosision exchange

water purification unit for the pharmaceutical industry
water purification unit for the pharmaceutical industry
Add to favorites
Compare this product
 

Characteristics

Applications
for the pharmaceutical industry
Options
reverse osmosis, ion exchange

Description

Granting an extremely low conductivity, Stilmas Reverse Osmosis + Electro Deionization (RO+EDI) plants constitute a reliable alternative to the traditional double stage Reverse Osmosis for the production purified water. Stilmas RO+EDI plants are fully designed in compliance with the standards requested by International Pharmacopoeias. Stilmas standard plants can cover a range of production from 500 liters per hour to 30.000 its per hour. Smaller and larger sizes are also available on request. Stilmas pure water production plants are in full compliance with the Standard request of Pharmacopoeias. CDI (Continous Deionization) technology. The operating principle consists in the generation of an electrical field into the water stream, which separates positive and negative ions, being then captured by ion exchange resins enclosed in the system. Captured salt ions are then released into a small stream of water (concentrate) and recycled into the feed water tank. CDI technology also grants a continuous regeneration of the resins. This way we avoid the contact of the CDI modules with external and potentially contaminated stream of water.

Catalogs

No catalogs are available for this product.

See all of STILMAS S.p.A.‘s catalogs

Exhibitions

Meet this supplier at the following exhibition(s):

ACHEMA 2024
ACHEMA 2024

10-14 Jun 2024 Frankfurt am Main (Germany)

  • More information
    *Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.